Home
Categories
Send inquiry
Home
About Us
About Gentolex
Factory Tour
Culture
FAQs
Products
Chemicals
Chemical Intermediates
Organic Chemicals
Inorganics Chemicals
Catalysts and Auxiliaries
Pharma Ingredients
Pharma APIs
Anti-Infective
Cardiovascular System
Other Apis
Reproductive System
Secretion System
Pharma Intermediates
Amino Acids
Cosmetics Peptide
Service
Procurement Service
CRO&CDMO
NEWS ROOM
Contact Us
Home
About Us
About Gentolex
Factory Tour
Culture
FAQs
Products
Chemicals
Chemical Intermediates
Organic Chemicals
Inorganics Chemicals
Catalysts and Auxiliaries
Pharma Ingredients
Pharma APIs
Anti-Infective
Cardiovascular System
Other Apis
Reproductive System
Secretion System
Pharma Intermediates
Amino Acids
Cosmetics Peptide
Service
Procurement Service
CRO&CDMO
NEWS ROOM
Contact Us
Featured
Home
News
News
Acadia Trofinetide Phase III Clinical Top-Line Results Positive
On 2021-12-06, US time, Acadia Pharmaceuticals (Nasdaq: ACAD) announced the positive top-line results of its Phase III clinical trial of its drug candidate, Trofinetide. The phase III trial, called Lavender, is mainly used to evaluate the safety and efficacy of Trofinetide in the treatment of Ret...
Read More
The research progress of opioid peptides from the approval of Difelikefalin
As early as 2021-08-24, Cara Therapeutics and its business partner Vifor Pharma announced that its first-in-class kappa opioid receptor agonist difelikefalin (KORSUVA™) was approved by the FDA for the treatment of chronic kidney disease (CKD) patients (positive Moderate/severe pruritus with hemod...
Read More
RhoVac Cancer Peptide Vaccine RV001 to be Patented by the Canadian Intellectual Property Office
Canada time 2022-01-24, RhoVac, a pharmaceutical company focused on tumor immunology, announced that its patent application (No. 2710061) for its cancer peptide vaccine RV001 will be authorized by the Canadian Intellectual Property Office (CIPO). Previously, the company has obtained patents relat...
Read More